Q3 2022 13F Holders as of 30 Sep 2022
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
24,391,791
-
Share change
-
-1,576,322
-
Total reported value
-
$15,665,736
-
Price per share
-
$0.64
-
Number of holders
-
50
-
Value change
-
-$1,252,322
-
Number of buys
-
13
-
Number of sells
-
30
Institutional Holders of AVROBIO INC - COM (AVRO) as of Q3 2022
As of 30 Sep 2022,
AVROBIO INC - COM (AVRO) was held by
50 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
24,391,791 shares.
The largest 10 holders included
Atlas Venture Life Science Advisors, LLC, GMT CAPITAL CORP, K2 PRINCIPAL FUND, L.P., BlackRock Inc., RENAISSANCE TECHNOLOGIES LLC, ACADIAN ASSET MANAGEMENT LLC, VANGUARD GROUP INC, Aisling Capital Management LP, FARALLON CAPITAL MANAGEMENT LLC, and MILLENNIUM MANAGEMENT LLC.
This page lists
50
institutional shareholders reporting positions in this security
for the Q3 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.